HCA Healthcare, Inc. Website

HCA Healthcare, Inc.

NYSE-HCA

Basic

  • Market Cap

    $92.4B

  • EV

    $137.28B

  • Shares Out

    261.91M

  • Revenue

    $68.35B

  • Employees

    265,000

Margins

  • Gross

    40.27%

  • EBITDA

    19.54%

  • Operating

    14.9%

  • Pre-Tax

    12.38%

  • Net

    8.4%

  • FCF

    7.15%

Returns (5Yr Avg)

  • ROA

    10.22%

  • ROTA

    257.33%

  • ROE

    20.15%

  • ROCE

    21.86%

  • ROIC

    17.13%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $373.76

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    $831M

  • Net Debt

    $41.94B

  • Debt/Equity

    31.94

  • EBIT/Interest

    5.11

Growth (CAGR)

  • Rev 3Yr

    6.86%

  • Rev 5Yr

    6.95%

  • Rev 10Yr

    6.81%

  • Dil EPS 3Yr

    13.48%

  • Dil EPS 5Yr

    15.45%

  • Dil EPS 10Yr

    19.69%

  • Rev Fwd 2Yr

    6.31%

  • EBITDA Fwd 2Yr

    5.25%

  • EPS Fwd 2Yr

    10.7%

  • EPS LT Growth Est

    10.67%

Dividends

  • Yield

    —

  • Payout

    11.67%

  • DPS

    $2.52

  • DPS Growth 3Yr

    37.95%

  • DPS Growth 5Yr

    10.93%

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    5.65%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Metric
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Total Revenues

51,336

51,533

58,752

60,233

64,968

68,347

Total Revenues % Chg.

10%

0.4%

14%

2.5%

7.9%

10.4%

Cost of Goods Sold, Total

32,041

32,243

36,260

37,056

39,389

40,824

Gross Profit

19,295

19,290

22,492

23,177

25,579

27,523

Selling General & Admin Expenses, Total

—

—

—

—

—

855

923

989

976

994

994

Depreciation & Amortization

2,596

2,721

2,853

2,969

3,077

3,172

Other Operating Expenses

8,626

8,384

8,972

10,179

11,881

13,173

Other Operating Expenses, Total

12,077

12,028

12,814

14,124

15,952

17,339

Operating Income

7,218

7,262

9,678

9,053

9,627

10,184

Interest Expense, Total

-1,824

-1,584

-1,566

-1,741

-1,938

-1,992

Net Interest Expenses

-1,824

-1,584

-1,566

-1,741

-1,938

-1,992

Income (Loss) On Equity Invest.

43

54

113

45

22

45

EBT, Excl. Unusual Items

5,437

5,732

8,225

7,357

7,711

8,237

Gain (Loss) On Sale Of Investments

—

—

—

—

—

—

—

—

—

—

Gain (Loss) On Sale Of Assets

18

-7

1,620

1,301

-5

222

Legal Settlements

—

—

—

—

—

—

—

—

Other Unusual Items

-211

-295

-12

-78

—

—

EBT, Incl. Unusual Items

5,244

5,430

9,833

8,580

7,706

8,459

Income Tax Expense

1,099

1,043

2,112

1,746

1,615

1,834

Earnings From Continuing Operations

4,145

4,387

7,721

6,834

6,091

6,625

Minority Interest

-640

-633

-765

-1,191

-849

-887

Net Income

3,505

3,754

6,956

5,643

5,242

5,738

Net Income to Common Incl Extra Items

3,505

3,754

6,956

5,643

5,242

5,738

Net Income to Common Excl. Extra Items

3,505

3,754

6,956

5,643

5,242

5,738

Total Shares Outstanding

338.4

339.4

305.5

277.4

265.5

264.1

Weighted Avg. Shares Outstanding

341.2

338.3

323.3

290.3

272.4

265.6

Weighted Avg. Shares Outstanding Dil

348.2

343.6

328.8

294.7

276.4

269.6

EPS

10.3

11.1

21.5

19.4

19.2

21.6

EPS Diluted

10.1

10.9

21.2

19.2

19

21.3

EBITDA

9,814

9,983

12,531

12,022

12,704

13,356

Effective Tax Rate

21%

19.2%

21.5%

20.3%

21%

21.7%